May is Pet Cancer Awareness Month

May is Pet Cancer Awareness Month, and vets and other experts across the country are hoping the month will bring awareness to the most common cause of disease-related death among pets.

Cancer is especially prevalent among certain breeds of canine, notably German Shepherds, Golden Retrievers and Rottweilers, breeds that in their lifetime can have an 80 percent risk of developing cancer.

Among other breeds, about 25 percent of all dogs will develop cancer, while among all dogs over the age of 10, there is a 50 percent chance of developing cancer.

The most frequently diagnosed form of cancer in pets is lymphoma, so pet owners can sometimes check their pets' lymph nodes to see if they're swollen, but experts instead urge pet owners to take their animals to their vets every 6-12 months for important check-ups, as the sooner any case of cancer is discovered the better the chances that treatments--chemotherapy, surgery, radiation, clinical trials--will work.

Pet owners are urged to limit any exposure to lawn car chemicals and pesticides, as well as maintaining a healthy weight, since researchers have linked cancer in animals to obesity.

Source: Cancer Treatment.net

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap